Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study update for BIND-014, a docetaxel nanoparticle formulation, in second-line non-small cell lung cancer (KRAS-positive and squamo…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of BIND-014, a docetaxel nanoparticle formulation, as second-line therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC [Phase 2]
Phase 2 study of carboplatin, pemetrexed, and panitumumab in advanced non-squamous KRAS wild-type non-small cell lung cancer has completed a…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?
This trial update notes the completion of a study evaluating whether epidermal growth factor receptor (EGFR)–targeted therapy can improve su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer [NA]
A clinical trial comparing multiple-portal VATS versus uniportal VATS lobectomy for non-small cell lung cancer; the current study status is …
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva) [Phase 1]
Phase 1 trial evaluating how itraconazole affects the pharmacokinetics of AZD9291 (osimertinib) in patients with EGFR-positive non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation [Phase 1]
Phase 1 clinical trial assessing whether Chinese herbal therapy based on syndrome differentiation can reduce chemotherapy toxicity while enh…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: RT Plus EGFR-TKI for Wild-type NSCLC [Phase 2]
A Phase 2 clinical trial update examines using radiation therapy plus an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TK…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Detection Cell Free DNA in Lung Cancer Patients
A clinical trial is evaluating the detection of cell-free DNA in patients with non-small cell lung cancer; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of combining apatinib with etoposide in heavily pretreated patients with advanced non-sma…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen-sponsored trial evaluating neutropenia and anemia management in patients with solid tumors receiving myelotoxic chemotherapy has compl…
-
CLINICAL_TRIALS research · 2016-04-06Clinical Trial Update: Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating individual boosting in non-small cell lung cancer using hypofractionation,…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial update examining the effect of food on AZD9291 (osimertinib) blood levels in patients with advanced non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) [Phase 1]
Phase I imaging trial evaluating dalotuzumab in combination with erlotinib for non-small cell lung cancer; the MK-0646-008 study has complet…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. [Phase 2]
Phase 2 study evaluating Tarceva (erlotinib) in combination with Gemcitabine in treatment-naive patients with advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer [Phase 4]
A Phase 4 clinical trial update describes an intercalated regimen of chemotherapy and tyrosine kinase inhibitors as first-line treatment for…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated radiation therapy with concurrent chemotherapy for non-small cell lung cancer; the study …
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer
An observational study evaluating Tarceva (erlotinib) as second-line treatment for non-small cell lung cancer in routine daily clinical prac…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification [Phase 2]
This Phase 2 trial assessed the efficacy and safety of SAR125844 in non-small cell lung cancer patients with MET amplification and has compl…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease
This clinical trial update analyzes outcomes and toxicity for patients with recurrent non-small cell lung cancer treated with high-dose re-i…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients
The study investigates correlations between MAGE-A3 and PRAME polymorphisms and their expression levels in non-small cell lung cancer, provi…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This update reports the results of a Phase I/II study evaluating fractionated stereotactic radiotherapy for early-stage non-small cell lung …
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure
This clinical trial update reports on a retrospective study examining treatment strategies used after first- or second-line failure of EGFR-…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
A study investigating how gene polymorphisms relate to normal tissue radiation injury in patients treated for several cancers; current statu…